News

TechMARK movers: Acambis rallies on Sanofi offer

28 July 2008 14:31:00

Acambis rallied after the smallpox vaccine developer announced late Friday that it has agreed a £276m cash offer from French drugs giant Sanofi Pasteur.

Acambis shareholders will get 190p a share.

"Sanofi Pasteur, which is one of the world's largest vaccines companies, will benefit strategically not only from Acambis' pipeline and technologies, but also from its significant US-based R&D and manufacturing infrastructure," said Acambis chairman Peter Fellner.

Shares in Pace dropped after the set-top box maker reported a slight drop in first half pre-tax profit due to £600,000 of exceptional costs.

The group, which supplies digital TV technology for BSkyB, said pre-tax profit fell to £10.5m for the six months to 30 June from £10.6m the year before on revenue up 22% to £231.1m. Profit before exceptionals was £11.2m.

Pace said the integration of its acquisition Royal Philips Electronics is progressing well and is already profitable.

FTSE TechMARK - Risers
Acambis (ACM) 185.50p +59.91%
Alizyme (AZM) 8.49p +21.63%
Vectura Group (VEC) 54.00p +8.00%
BTG (BGC) 202.75p +6.71%
Optos (OPTS) 155.00p +6.16%
ProStrakan (PSK) 79.50p +6.00%
Biocompatibles International (BII) 162.00p +5.88%
SDL International (SDL) 372.00p +5.83%
Phoenix IT Group (PNX) 290.00p +3.02%
Oxford Instruments (OXIG) 230.00p +2.91%

FTSE TechMARK - Fallers
Inion (IIN) 6.00p -17.24%
AEA Technology (AAT) 41.75p -11.17%
Alphameric (ALM) 17.00p -6.85%
Pace (PIC) 83.00p -5.14%
Torotrak (TRK) 19.00p -5.00%
Vtech (VTH) 247.50p -3.88%
Turbo Power Systems (TPS) 3.25p -3.70%
Corin Group (CRG) 143.00p -3.38%
Redstone (RED) 47.00p -2.08%
Anite Group (AIE) 35.25p -2.08%

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.